FDA Approves Trelegy Ellipta for COPD - Medscape
Sep 19, 2017 · The FDA has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta, GlaxoSmithKline) for patients with COPD.
FDA Expands Indication for Trelegy Ellipta in COPD - Medscape
Apr 24, 2018 · The FDA first approved Trelegy Ellipta in September 2017 for the long-term, once-daily maintenance treatment of COPD patients who are receiving Breo Ellipta (fluticasone …
FDA Approves Umeclidinium and Vilanterol Combo for COPD
Dec 18, 2013 · The FDA has approved umeclidinium and vilanterol powder for inhalation for long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease.
EU Approves Trelegy Ellipta for COPD - Medscape
Nov 16, 2017 · The European Commission has granted marketing authorization for fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta, GlaxoSmithKline PLC and Innoviva, Inc ...
FDA OKs Umeclidinium (Incruse Ellipta) for COPD - Medscape
Apr 30, 2014 · The once-daily anticholinergic is approved for maintenance treatment of airflow obstruction in patients with COPD.
Will This Urine Test Be a Biopsy Killer for PC? - Medscape
Dec 8, 2025 · The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them avoid biopsies.
Canada Clears Umeclidinium (Incruse) for COPD - Medscape
Apr 18, 2014 · The long-acting muscarinic antagonist is indicated for long-term maintenance bronchodilator treatment of airflow obstruction in adults with COPD.
BP Meds Should Begin Promptly, New ACC/AHA Guidelines Say
Aug 14, 2025 · The new guidelines lower the threshold for beginning blood pressure medications, among other notable changes.
Advanced MRI Scanner Promises Better Cancer Detection
Feb 27, 2025 · New MRI scanning technology developed at Aberdeen University could improve cancer detection and reduce repeat surgeries by distinguishing tumours with greater accuracy.
The Era of Compounded GLP-1 Drugs Is Over. What Now?
Apr 10, 2025 · Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.